On July 19th, 21st Jinqiao Industrial Technology Innovation Conference was held at SAST, with the theme of “Stem Cell Fundamental Researches and Clinical Application in China and Germany”. It is a deep discussion on recent years’ new technologies and new methods in the area. Mr. Niu Xiaoming, president of SAST and SITI, Mr. Cao Amin, vice president of SAST, attended and meeting.

Prof. Juergen Hescheler, chief scientist of Shanghai Hescheler Institute, SITI, and director, Institute of Neurophysiology, University of Cologne, and Prof. Feng Chuanliang, vice president, School of Material Science and Engineering, Shanghai Jiaotong University, gave keynote talks respectively on “Applied Researches of Pluripotent Stem Cells at Shanghai Hescheler Institute, SITI” and “Bioinspired Chiral Supramolecular Hydrogels”. Mr. Werner Stump, Council Member of Shanghai Hescheler Institute, and president of Cologne Bonn Regional Healthcare Association, Germany, introduced the plan of Germany on application-oriented medical researches. Prof. Huang Zhengwei, No.9 People’s Hospital affiliated to Shanghai Jiaotong University, and Dr. Tomo Saric, research leader at Institute of Neurophysiology, University of Cologne, gave invited talks on clinical application of stem cells and purification of stem cells.

On the meeting, the initialization ceremony for Shanghai Hescheler Institute Laboratory was held and the first sale contract was signed. There were totally more than 40 participants from Shanghai Hescheler Institute, University of Cologne, Shanghai Jiaotong University, various enterprises and investment institutions. After the talks, there were also discussions on possible applications of stem cells in systemic diseases, immune system diseases and nervous system diseases as well as on construction of research alliance between China and Germany.